Corpus Intelligence IC Memo — LIMA MEMORIAL HOSPITAL 2026-04-26 11:18 UTC
IC Memo — LIMA MEMORIAL HOSPITAL
Investment Committee Memorandum | OH | 110 beds | Grade B | EBITDA uplift $18.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

LIMA MEMORIAL HOSPITAL

CCN 360009 | ALLEN, OH | 110 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

LIMA MEMORIAL HOSPITAL is a 110-bed suburban community hospital in ALLEN, OH with $253.5M in net patient revenue and a 6.4% operating margin. The hospital serves a payer mix of 31.0% Medicare, 3.9% Medicaid, and 65.1% commercial.

Thesis: Turnaround. Our ML models identify $18.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 6.4% to 13.8% (+736bps).

Net Revenue HCRIS$253.5M
Current EBITDA COMPUTED$16.3M
Operating Margin COMPUTED6.4%
Occupancy HCRIS62.7%
Revenue / Bed COMPUTED$2.3M
Net-to-Gross HCRIS29.6%
Distress Probability ML43.7%

2. Market Context & Competitive Position

235
OH Hospitals
-0.3%
State Median Margin
100
Comparable Hospitals

OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of 6.4% places it above the state median. Among 100 size-comparable peers (55-220 beds), the median margin is 1.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (55-220), prioritizing same-state peers. 100 hospitals in the comp set.

HospitalStateBedsRevenueMargin
LIMA MEMORIAL HOSPITAL (Target)OH110$253.5M6.4%
DAYTON CHILDRENS HOSPITALOH181$569.1M7.9%
MARIETTA MEMORIAL HOSPITALOH188$475.8M-12.4%
ADENA REGIONAL MEDICAL CENTEROH209$470.7M3.5%
SOUTHERN OHIO MEDICAL CENTEROH192$424.3M-4.9%
SOUTHWEST GENERAL HEALTH CENTEOH191$406.9M2.5%
MARION GENERAL HOSPITALOH177$365.7M35.5%
DUBLIN METHODIST HOSPITALOH110$333.9M28.4%
JEWISH HOSPITAL OF CINCINNATIOH170$333.6M-5.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $18.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$5.3M+210bp18mo
Cost to Collect4.5%2.5%$5.1M+200bp12mo
Denial Rate Reduction12.0%6.5%$5.0M+198bp12mo
A/R Days Reduction5200.0%3800.0%$3.1M+122bp9mo
Clean Claim Rate88.0%96.0%$162K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$5.3M
Cost to Collect
$5.1M
Denial Rate Reduction
$5.0M
A/R Days Reduction
$3.1M
Clean Claim Rate
$162K
Total EBITDA Uplift$18.7M
Current EBITDA$16.3M
+ RCM Uplift+$18.7M
Pro Forma EBITDA$34.9M
Current Margin6.4%
Pro Forma Margin13.8%
WC Released (1x)$9.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$25.0M$293.9M11.75x63.7%
Base (11x exit)10.0x11.0x$25.0M$331.4M13.25x67.7%
Bull Case9.0x11.0x$22.5M$401.1M17.81x77.9%
Bull (12x exit)9.0x12.0x$22.5M$444.2M19.73x81.6%
Bear Case11.0x10.0x$27.5M$192.4M6.99x47.5%
Bear (11x exit)11.0x11.0x$27.5M$220.6M8.02x51.6%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 100 hospitals with 55-220 beds
  • Same-state prioritization (n=101)
  • Comp margins: P25=-12.4% / P50=1.4% / P75=8.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.